在患有转移性癌症而没有心力衰竭的患者中,脑内尿素的升高:一个案例研究
Leon L Chen1,2, Alina O Dulu1,3, Stephen M Pastores1,3
1Department of Anesthesiology and Critical Care Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
概括
大脑中尿素 (BNP) 水平升高可能表明心力衰竭,但恶性瘤也可能导致高BNP. 本案例报告强调将癌症视为BNP升高的原因,特别是当心力衰竭不存在时.
科学领域:
- 生物化学 生物化学
- 在瘤学瘤学.
- 心脏病学 心脏病学
背景情况:
- 脑性尿素 (BNP) 是诊断心力衰竭 (HF) 的关键生物标志物.
- 升高的BNP水平可能发生在其他疾病,比如慢性功能衰竭和败血症,复杂的诊断.
- 恶性病症通常不被认为是显著升高的BNP的直接原因.
研究的目的:
- 报告一种罕见的病例,在患有转移性尿路细胞癌的患者中,血清BNP水平明显升高.
- 突出恶性瘤可能导致BNP显著增加的可能性.
- 强调考虑BNP升高的替代诊断的重要性,特别是癌症患者.
主要方法:
- 一个患有转移性尿路细胞癌的患者的病例报告.
- 对血清脑内尿素 (BNP) 水平的分析.
- 对心力衰竭和败血症的临床评估.
主要成果:
- 这位患者呈现出明显升高的血清BNP水平.
- 没有发现心力衰竭或败血症的证据.
- 诊断出了转移性尿路细胞癌.
结论:
- 恶性病,特别是转移性尿路细胞癌,可以导致血清BNP水平明显升高.
- 对BNP的诊断解释需要考虑伴随疾病,包括癌症.
- 进一步研究癌症和BNP升高之间的机制可能是有必要的.
相关概念视频
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
119
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
119
Heart Failure II: Pathophysiology
16
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
16
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
465
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
465
Hormonal Regulation of Blood Pressure
2.7K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
2.7K


